Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Avanos Medical Inc shares valued at $106,778 were sold by Holbrook Kerr on Mar 06 ’25. At $15.25 per share, Holbrook Kerr sold 7,000 shares. The insider’s holdings dropped to 82,047 shares worth approximately $1.0 million following the completion of this transaction.
Also, Holbrook Kerr purchased 7,000 shares, netting a total of over 106,780 in proceeds.
As published in a research note from KeyBanc Capital Markets on July 25, 2023, Avanos Medical Inc [AVNS] has been rated down from an Overweight to a Sector weight. Analysts at CL King started covering the stock with ‘”a Buy”‘ outlook in a report released in late May. As of August 04, 2021, Stephens has decreased its “an Overweight” rating to a “an Equal-weight” for AVNS. Earlier on April 13, 2020, Barclays upgraded its rating. Their new recommendation was “an Equal weight” for AVNS stock which previously was a “an Underweight”.
Analyzing AVNS Stock Performance
During the last five days, there has been a drop of approximately -3.42%. Over the course of the year, Avanos Medical Inc shares have dropped approximately -23.68%. Shares of the company reached a 52-week high of $17.69 on 01/30/25 and a 52-week low of $11.84 on 04/21/25. A 50-day SMA is recorded $13.43, while a 200-day SMA reached $18.29.
Support And Resistance Levels for Avanos Medical Inc (AVNS)
According to the 24-hour chart, there is a support level at 11.94, which, if violated, would cause prices to drop to 11.74. In the upper region, resistance lies at 12.51. The next price resistance is at 12.88. RSI (Relative Strength Index) is 40.62 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at 0.10, which suggests the price will decrease in the coming days. Percent R is at 90.59%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
